{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:04:26Z","timestamp":1769000666342,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s13346-017-0426-z","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T19:55:35Z","timestamp":1508788535000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Inhibiting influenza virus replication and inducing protection against lethal influenza virus challenge through chitosan nanoparticles loaded by siRNA"],"prefix":"10.1007","volume":"8","author":[{"given":"Abbas","family":"Jamali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Mottaghitalab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asghar","family":"Abdoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meshkat","family":"Dinarvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Esmailie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh Tavassoti","family":"Kheiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Atyabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"426_CR1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1749-6632.2010.05451.x","volume":"1195","author":"KJ Vandegrift","year":"2010","unstructured":"Vandegrift KJ, Sokolow SH, Daszak P, Kilpatrick AM. Ecology of avian influenza viruses in a changing world. Ann N Y Acad Sci. 2010;1195:113\u201328.","journal-title":"Ann N Y Acad Sci"},{"key":"426_CR2","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1016\/j.vaccine.2008.09.057","volume":"26","author":"N Hagenaars","year":"2008","unstructured":"Hagenaars N, Mastrobattista E, Glansbeek H, Heldens J, van den Bosch H, Schijns V, et al. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model. Vaccine. 2008;26:6555\u201363.","journal-title":"Vaccine"},{"key":"426_CR3","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","volume":"353","author":"MD Jong De","year":"2005","unstructured":"De Jong MD, Thanh TT, Khanh TH, Hien VM, Smith GJ, Chau NV, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005;353:2667\u201372.","journal-title":"N Engl J Med"},{"key":"426_CR4","doi-asserted-by":"crossref","first-page":"g2545","DOI":"10.1136\/bmj.g2545","volume":"348","author":"T Jefferson","year":"2014","unstructured":"Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014;348:g2545.","journal-title":"BMJ"},{"key":"426_CR5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","volume":"136","author":"RW Carthew","year":"2009","unstructured":"Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:642\u201355.","journal-title":"Cell"},{"key":"426_CR6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature02873","volume":"431","author":"G Meister","year":"2004","unstructured":"Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature. 2004;431:343\u20139.","journal-title":"Nature"},{"key":"426_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","volume":"8","author":"KA Whitehead","year":"2009","unstructured":"Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009;8:129\u201338.","journal-title":"Nat Rev Drug Discov"},{"key":"426_CR8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/14728222.12.5.637","volume":"12","author":"C Huang","year":"2008","unstructured":"Huang C, Li M, Chen C, Yao Q. Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications. Expert Opin Ther Targets. 2008;12:637\u201345.","journal-title":"Expert Opin Ther Targets"},{"key":"426_CR9","first-page":"2119","volume":"119","author":"PJ Mishra","year":"2009","unstructured":"Mishra PJ, Merlino G. MicroRNA reexpression as differentiation therapy in cancer. J Clin Invest. 2009;119:2119\u201323.","journal-title":"J Clin Invest"},{"key":"426_CR10","doi-asserted-by":"crossref","first-page":"8676","DOI":"10.1073\/pnas.0402486101","volume":"101","author":"Q Ge","year":"2004","unstructured":"Ge Q, Filip L, Bai A, Nguyen T, Eisen HN, Chen J. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci U S A. 2004;101:8676\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"426_CR11","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1111\/j.1742-4658.2010.07904.x","volume":"277","author":"MS Shim","year":"2010","unstructured":"Shim MS, Kwon YJ. Efficient and targeted delivery of siRNA in vivo. FEBS J. 2010;277:4814\u201327.","journal-title":"FEBS J"},{"key":"426_CR12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1021\/bm061140p","volume":"8","author":"S Zivanovic","year":"2007","unstructured":"Zivanovic S, Li J, Davidson PM, Kit K. Physical, mechanical, and antibacterial properties of chitosan\/PEO blend films. Biomacromolecules. 2007;8:1505\u201310.","journal-title":"Biomacromolecules"},{"key":"426_CR13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.biotechadv.2009.11.001","volume":"28","author":"R Jayakumar","year":"2010","unstructured":"Jayakumar R, Prabaharan M, Nair S, Tamura H. Novel chitin and chitosan nanofibers in biomedical applications. Biotechnol Adv. 2010;28:142\u201350.","journal-title":"Biotechnol Adv"},{"key":"426_CR14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2174\/138161208799316410","volume":"14","author":"J Vinsova","year":"2008","unstructured":"Vinsova J, Vavrikova E. Recent advances in drugs and prodrugs design of chitosan. Curr Pharm Des. 2008;14:1311\u201326.","journal-title":"Curr Pharm Des"},{"key":"426_CR15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2006.07.021","volume":"115","author":"H Katas","year":"2006","unstructured":"Katas H, Alpar HO. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release. 2006;115:216\u201325.","journal-title":"J Control Release"},{"key":"426_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2009.08.004","volume":"62","author":"S Mao","year":"2010","unstructured":"Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev. 2010;62:12\u201327.","journal-title":"Adv Drug Deliv Rev"},{"key":"426_CR17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ymthe.2006.04.010","volume":"14","author":"KA Howard","year":"2006","unstructured":"Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen M\u00d8, et al. RNA interference in vitro and in vivo using a chitosan\/siRNA nanoparticle system. Mol Ther. 2006;14:476\u201384.","journal-title":"Mol Ther"},{"key":"426_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","volume":"51","author":"L Illum","year":"2001","unstructured":"Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher A, Davis S. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev. 2001;51:81\u201396.","journal-title":"Adv Drug Deliv Rev"},{"key":"426_CR19","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","volume":"7","author":"L Illum","year":"2002","unstructured":"Illum L. Nasal drug delivery: new developments and strategies. Drug Discov Today. 2002;7:1184\u20139.","journal-title":"Drug Discov Today"},{"key":"426_CR20","volume":"4","author":"H-Y Sui","year":"2009","unstructured":"Sui H-Y, Zhao G-Y, Huang J-D, Jin D-Y, Yuen K-Y, Zheng B-J. Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication. PLoS One. 2009;4:e5671.","journal-title":"PLoS One"},{"key":"426_CR21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1208\/s12249-013-0058-7","volume":"15","author":"C Sawaengsak","year":"2014","unstructured":"Sawaengsak C, Mori Y, Yamanishi K, Mitrevej A, Sinchaipanid N. Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine. AAPS PharmSciTech. 2014;15:317\u201325.","journal-title":"AAPS PharmSciTech"},{"key":"426_CR22","volume-title":"Chitosan\/interfering RNA nanoparticle mediated gene silencing in disease vector mosquito larvae","author":"X Zhang","year":"2015","unstructured":"Zhang X, Mysore K, Flannery E, Michel K, Severson DW, Zhu KY, et al. Chitosan\/interfering RNA nanoparticle mediated gene silencing in disease vector mosquito larvae. JoVE: Journal of visualized experiments; 2015."},{"key":"426_CR23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/08982100601186516","volume":"17","author":"A Huckriede","year":"2007","unstructured":"Huckriede A, De Jonge J, Holtrop M, Wilschut J. Cellular delivery of siRNA mediated by fusion-active virosomes. Journal of liposome research. 2007;17:39\u201347.","journal-title":"Journal of liposome research"},{"key":"426_CR24","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/v2071448","volume":"2","author":"S Barik","year":"2010","unstructured":"Barik S. siRNA for influenza therapy. Viruses. 2010;2:1448\u201357.","journal-title":"Viruses"},{"key":"426_CR25","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(03)14637-5","volume":"362","author":"NR Wall","year":"2003","unstructured":"Wall NR, Shi Y. Small RNA: can RNA interference be exploited for therapy? Lancet. 2003;362:1401\u20133.","journal-title":"Lancet"},{"key":"426_CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0928-0987(01)00172-5","volume":"14","author":"IM Lubben van der","year":"2001","unstructured":"van der Lubben IM, Verhoef JC, Borchard G, Junginger HE. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci. 2001;14:201\u20137.","journal-title":"Eur J Pharm Sci"},{"key":"426_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2004.05.019","volume":"281","author":"S Mao","year":"2004","unstructured":"Mao S, Shuai X, Unger F, Simon M, Bi D, Kissel T. The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm. 2004;281:45\u201354.","journal-title":"Int J Pharm"},{"key":"426_CR28","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1039\/c0np00005a","volume":"27","author":"H Ge","year":"2010","unstructured":"Ge H, Wang Y-F, Xu J, Gu Q, Liu H-B, Xiao P-G, et al. Anti-influenza agents from traditional Chinese medicine. Nat Prod Rep. 2010;27:1758\u201380.","journal-title":"Nat Prod Rep"},{"key":"426_CR29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030242","volume":"3","author":"DM Dykxhoorn","year":"2006","unstructured":"Dykxhoorn DM, Lieberman J. Silencing viral infection. PLoS Med. 2006;3:e242.","journal-title":"PLoS Med"},{"key":"426_CR30","volume":"6","author":"F Ahmed","year":"2011","unstructured":"Ahmed F, Raghava GP. Designing of highly effective complementary and mismatch siRNAs for silencing a gene. PLoS One. 2011;6:e23443.","journal-title":"PLoS One"},{"key":"426_CR31","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1021\/bm015548s","volume":"2","author":"N Fang","year":"2001","unstructured":"Fang N, Chan V, Mao H-Q, Leong KW. Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH. Biomacromolecules. 2001;2:1161\u20138.","journal-title":"Biomacromolecules"},{"key":"426_CR32","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1128\/AAC.01664-12","volume":"56","author":"DF Smee","year":"2012","unstructured":"Smee DF, von Itzstein M, Bhatt B, Tarbet EB. Exacerbation of influenza virus infections in mice by intranasal treatments and implications for evaluation of antiviral drugs. Antimicrob Agents Chemother. 2012;56:6328\u201333.","journal-title":"Antimicrob Agents Chemother"},{"key":"426_CR33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128794","volume":"10","author":"M Morokutti-Kurz","year":"2015","unstructured":"Morokutti-Kurz M, K\u00f6nig-Schuster M, Koller C, Graf C, Graf P, Kirchoff N, et al. The intranasal application of zanamivir and carrageenan is synergistically active against influenza A virus in the murine model. PLoS One. 2015;10:e0128794.","journal-title":"PLoS One"},{"key":"426_CR34","first-page":"20095","volume":"7","author":"EJ Jeong","year":"2015","unstructured":"Jeong EJ, Choi M, Lee J, Rhim T, Lee KY. The spacer arm length in cell-penetrating peptides influences chitosan\/siRNA nanoparticle delivery for pulmonary inflammation treatment. Nano. 2015;7:20095\u2013104.","journal-title":"Nano"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-017-0426-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0426-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-017-0426-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T11:38:48Z","timestamp":1515152328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-017-0426-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1007\/s13346-017-0426-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}